Диссертация (1174360), страница 26
Текст из файла (страница 26)
66-72.119. Holmström M., Åberg W., Lockner D.Paul C., Long-term clinical follow-up in265 patients with deep venous thrombosis initially treated with either unfractionatedheparin or dalteparin: a retrospective analysis. Thrombosis and haemostasis, 1999.82(4): p. 1222-1226.120. Hong C., Zhu F., Du D., Pilgram T.K., Sicard G.A., et al., Coronary arterycalcification and risk factors for atherosclerosis in patients with venousthromboembolism. Atherosclerosis, 2005.
183(1): p. 169-74.121. Huisman M.V., Buller H.R., Ten Cate J.W., Van Royen E.A., Vreeken J., et al.,Unexpected high prevalence of silent pulmonary embolism in patients with deep venousthrombosis. Chest, 1989. 95(3): p. 498-502.122. Hull R., Delmore T., Genton E., Hirsh J., Gent M., et al., Warfarin sodium versuslow-dose heparin in the long-term treatment of venous thrombosis. New EnglandJournal of Medicine, 1979.
301(16): p. 855-858.123. Hull R.D., Liang J.Townshend G., Long-term low-molecular-weight heparin andthe post-thrombotic syndrome: a systematic review. The American journal of medicine,2011. 124(8): p. 756-765.124. Hull R.D., Pineo G.F., Brant R., Liang J., Cook R., et al., Home therapy ofvenous thrombosis with long-term LMWH versus usual care: patient satisfaction and146post-thrombotic syndrome. The American journal of medicine, 2009. 122(8): p. 762769. e3.125. Hull R.D., Raskob G.E., Hirsh J., Jay R.M., Leclerc J.R., et al., Continuousintravenous heparin compared with intermittent subcutaneous heparin in the initialtreatment of proximal-vein thrombosis.
New England Journal of Medicine, 1986.315(18): p. 1109-1114.126. Ibegbuna V., Delis K.T., Nicolaides A.N.Aina O., Effect of elastic compressionstockings on venous hemodynamics during walking. J Vasc Surg, 2003. 37(2): p. 420-5.127. Immelman E.Jeffery P., The postphlebitic syndrome. Pathophysiology,prevention and management. Clinics in chest medicine, 1984. 5(3): p. 537.128. Investigators E.-P., Buller H.R., Prins M.H., Lensin A.W., Decousus H., et al.,Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med,2012. 366(14): p. 1287-97.129.
Investigators E., Bauersachs R., Berkowitz S.D., Brenner B., Buller H.R., et al.,Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med, 2010.363(26): p. 2499-510.130. Iorio A., Kearon C., Filippucci E., Marcucci M., Macura A., et al., Risk ofrecurrence after a first episode of symptomatic venous thromboembolism provoked by atransient risk factor: a systematic review. Arch Intern Med, 2010.
170(19): p. 1710-6.131. Janakiram M., Sullivan M., Shcherba M., Guo S.Billett H.H., A systematicreview of the utility of residual vein obstruction studies in primary and secondaryvenous thrombosis. Thrombosis, 2013. 2013.132. Janssen T.W.Hopman M.T., Blood flow response to electrically induced twitchand tetanic lower-limb muscle contractions. Archives of physical medicine andrehabilitation, 2003. 84(7): p. 982-987.133. Jantet G., Chronic venous insufficiency: worldwide results of the RELIEF study.Angiology, 2002.
53(3): p. 245-256.134. Jayaraj A.Meissner M.H., A comparison of Villalta-Prandoni scale and venousclinical severity score in the assessment of post thrombotic syndrome. Annals ofvascular surgery, 2014. 28(2): p. 313-7.135. Johnson B.F., Manzo R.A., Bergelin R.O.Strandness D.E., Relationship betweenchanges in the deep venous system and the development of the postthromboticsyndrome after an acute episode of lower limb deep vein thrombosis: a one-to six-yearfollow-up. Journal of vascular surgery, 1995.
21(2): p. 307-313.136. Jones N.A., Webb P.J., Rees R.I.Kakkar V.V., A physiological study of elasticcompression stockings in venous disorders of the leg. Br J Surg, 1980. 67(8): p. 569-72.147137. Jull A.B., Arroll B., Parag V.Waters J., Pentoxifylline for treating venous legulcers. Cochrane Database Syst Rev, 2012. 12: p. CD001733.138. Kahn S., Desmarais S., Ducruet T., Arsenault L.Ginsberg J., Comparison of theVillalta and Ginsberg clinical scales to diagnose the post‐thrombotic syndrome:correlation with patient‐reported disease burden and venous valvular reflux.
Journal ofThrombosis and Haemostasis, 2006. 4(4): p. 907-908.139. Kahn S., Kearon C., Julian J., Mackinnon B., Kovacs M., et al., Predictors of thepost‐thrombotic syndrome during long‐term treatment of proximal deep veinthrombosis. Journal of Thrombosis and Haemostasis, 2005. 3(4): p.
718-723.140. Kahn S., M'lan C., Lamping D., Kurz X., Berard A., et al., The influence ofvenous thromboembolism on quality of life and severity of chronic venous disease.Journal of thrombosis and haemostasis, 2004. 2(12): p. 2146-2151.141. Kahn S.R., How I treat postthrombotic syndrome. Blood, 2009. 114(21): p. 462431.142. Kahn S.R., Ducruet T., Lamping D.L., Arsenault L., Miron M.J., et al.,Prospective evaluation of health-related quality of life in patients with deep venousthrombosis. Archives of Internal Medicine, 2005.
165(10): p. 1173-1178.143. Kahn S.R., Elman E., Rodger M.A.Wells P.S., Use of elastic compressionstockings after deep venous thrombosis: a comparison of practices and perceptions ofthrombosis physicians and patients. Journal of thrombosis and haemostasis : JTH, 2003.1(3): p. 500-6.144. Kahn S.R., Galanaud J.P., Vedantham S.Ginsberg J.S., Guidance for theprevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis,2016. 41(1): p. 144-53.145.
Kahn S.R.Ginsberg J.S., Relationship between deep venous thrombosis and thepostthrombotic syndrome. Archives of internal medicine, 2004. 164(1): p. 17-26.146. Kahn S.R., Hirsch A.Shrier I., Effect of postthrombotic syndrome on healthrelated quality of life after deep venous thrombosis. Archives of internal medicine,2002. 162(10): p. 1144-1148.147. Kahn S.R., Partsch H., Vedantham S., Prandoni P.Kearon C., Definition of postthrombotic syndrome of the leg for use in clinical investigations: a recommendation forstandardization. Journal of thrombosis and haemostasis : JTH, 2009. 7(5): p.
879-83.148. Kahn S.R., Shapiro S., Wells P.S., Rodger M.A., Kovacs M.J., et al.,Compression stockings to prevent post-thrombotic syndrome: a randomised placebocontrolled trial. Lancet, 2014. 383(9920): p. 880-8.148149. Kahn S.R., Shbaklo H., Lamping D.L., Holcroft C.A., Shrier I., et al.,Determinants of health-related quality of life during the 2 years following deep veinthrombosis. J Thromb Haemost, 2008. 6(7): p. 1105-12.150.
Kahn S.R., Shrier I., Julian J.A., Ducruet T., Arsenault L., et al., Determinantsand time course of the postthrombotic syndrome after acute deep venous thrombosis.Annals of internal medicine, 2008. 149(10): p. 698-707.151. Kahn S.R., Shrier I., Shapiro S., Houweling A.H., Hirsch A.M., et al., Six-monthexercise training program to treat post-thrombotic syndrome: a randomized controlledtwo-centre trial. Canadian Medical Association Journal, 2011. 183(1): p. 37-44.152.
Kan Y.M.Delis K.T., Hemodynamic effects of supervised calf muscle exercise inpatients with venous leg ulceration: a prospective controlled study. Archives of Surgery,2001. 136(12): p. 1364-1369.153. Kaplan R.E., Czyrny J.J., Fung T.S., Unsworth J.D.Hirsh J., Electrical footstimulation and implications for the prevention of venous thromboembolic disease.THROMBOSIS AND HAEMOSTASIS-STUTTGART-, 2002.
88(2): p. 200-204.154. Kearon C., Akl E.A., Ornelas J., Blaivas A., Jimenez D., et al., AntithromboticTherapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 2016.149(2): p. 315-52.155. Killewich L.A., Bedford G.R., Beach K.W.Strandness D., Spontaneous lysis ofdeep venous thrombi: rate and outcome.
Journal of vascular surgery, 1989. 9(1): p. 8997.156. Killewich L.A., Macko R.F., Cox K., Franklin D.R., Benjamin M.E., et al.,Regression of proximal deep venous thrombosis is associated with fibrinolyticenhancement. Journal of vascular surgery, 1997. 26(5): p. 861-868.157. Kistner R.L., Ball J.J., Nordyke R.A.Freeman G.C., Incidence of pulmonaryembolism in the course of thrombophlebitis of the lower extremities. Am J Surg, 1972.124(2): p. 169-76.158.
Kolbach D., Neumann H.Prins M., Definition of the post-thrombotic syndrome,differences between existing classifications. European journal of vascular andendovascular surgery, 2005. 30(4): p. 404-414.159. Konstantinides S.V., Torbicki A., Agnelli G., Danchin N., Fitzmaurice D., et al.,2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.Eur Heart J, 2014.
35(43): p. 3033-69, 3069a-3069k.160. Krieger E., Van Der Loo B., Amann-Vesti B.R., Rousson V.Koppensteiner R., Creactive protein and red cell aggregation correlate with late venous function after acutedeep venous thrombosis. Journal of vascular surgery, 2004. 40(4): p. 644-649.149161. Krupski W.C., Bass A., Dilley R.B., Bernstein E.F.Otis S.M., Propagation ofdeep venous thrombosis identified by duplex ultrasonography. Journal of vascularsurgery, 1990. 12(4): p. 467-475.162. Labropoulos N., Tiongson J., Pryor L., Tassiopoulos A.K., Kang S.S., et al.,Definition of venous reflux in lower-extremity veins.
Journal of vascular surgery, 2003.38(4): p. 793-8.163. Lagerstedt C., Olsson C.-G., Fagher B., Norgren L.Tengborn L., Recurrence andlate sequelae after first-time deep vein thrombosis: relationship to initial signs.Phlebology, 1993. 8(2): p. 62-67.164. Lattimer C.R., Kalodiki E., Azzam M.Geroulakos G., Validation of the Villaltascale in assessing post-thrombotic syndrome using clinical, duplex, and hemodynamiccomparators. Journal of vascular surgery. Venous and lymphatic disorders, 2014. 2(1):p.
8-14.165. Laurent R., Gilly R.Frileux C., Clinical evaluation of a venotropic drug in man.Example of Daflon 500 mg. International angiology: a journal of the InternationalUnion of Angiology, 1987. 7(2 Suppl): p. 39-43.166. Lawenda B.D., Mondry T.E.Johnstone P.A., Lymphedema: a primer on theidentification and management of a chronic condition in oncologic treatment. CA: acancer journal for clinicians, 2009.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
